Announcements
- Initial positive data from Phase 2 of BEXMAB
- Issuance of warrants
- Founders named European Inventor Award finalists
- Replacement – Board Change
- Update on financial status
- Board Change
- Faron confirms plans under new leadership
- Appointment of Chief Financial Officer
- Approval of Warrant Terms and Conditions
- Decisions of the Board of Directors
More ▼
Key statistics
On Monday, Faron Pharmaceuticals Oy (FARON:HEX) closed at 2.36, 74.19% above the 52 week low of 1.35 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.37 |
---|---|
High | 2.45 |
Low | 2.31 |
Bid | 2.36 |
Offer | 2.36 |
Previous close | 2.36 |
Average volume | 168.45k |
---|---|
Shares outstanding | 72.01m |
Free float | 43.72m |
P/E (TTM) | -- |
Market cap | 133.23m GBP |
EPS (TTM) | -0.4038 GBP |
Data delayed at least 15 minutes, as of Jun 03 2024 17:00 BST.
More ▼